At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Paris based CFO’ operating in the Health Care space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected]
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
CFO of Kurma Partners
More than 15 years of experience in Finance & Administration. Previously entrepreneur and CFO for Nekazen/Le MAG VoD. Fund controller & Internal Auditor for Jones Lang LaSalle. Tax Advisor with Arthur Andersen. Sylvain joined Kurma in January 2013.
Follow Sylvain Cascarino:
About Kurma Partners: Kurma Partners is a management company specializing in the financing of innovation in healthcare and biotechnology.
CFO of GenSight Biologics
Thomas Gidoin has been GenSight Biologics’ Chief Financial Officer since June 2015. From 2012 to mid-2015, Thomas was Vice President Finance at DBV Technologies S.A., where he led the Corporate Finance team and participated in public offerings and private placements, including the dual listing of DBV Technologies on the Nasdaq Global Select Market in 2014. From 2008 to 2011, he served in various positions at Ipsen S.A., including UK Operations Controller in London and Senior Financial Analyst in the Global Operations division in Paris. He started his career in audit at Ernst & Young. Thomas received a Master’s degree in International Finance from ESGF Paris and a Master’s degree in International Management from Neoma Business School in France.
Follow Thomas Gidoin:
About GenSight Biologics: GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.
CFO of Corwave
Zina Hamoumi brings more than 15 years of experience in corporate finance and accounting, including 7 years in the life sciences sector. She started her career at PwC in the audit practice, before moving to operational roles at Mexx (retail) and then Lundbeck France (pharmaceuticals), where she was Head of Finance and Logistics, overseeing financial operations that included sales, production, and R&D activities. She subsequently joined Victoria Beckham Ltd (fashion/retail) in London in 2014 as Finance Director. She supported the fast-growing business, put in place solid financial processes, and played an instrumental role in setting up a private equity round of funding. Zina holds a Msc in Management from EM Lyon business school.
Follow Zina Hamoumi:
About Corwave: CorWave is a medical device company developing innovative heart pumps.
Chief Financial Officer of ENTEROME
Christelle Dumoussaud has served as our Chief Financial Officer since 2015. Ms. Dumoussaud has more than 20 years’ experience in financial departments of various industries. In 2015, Ms. Dumoussaud served as General Secretary at Laboratoire Hepatoum-Dermophil Indien and Ms. Dumoussaud served as a financial consultant at Expert & Consult in 2014. From 2012 to 2013, Ms. Dumoussaud served as Administration and Finance Manager at Almavia and from 2007 to 2012, Ms. Dumoussaud served as General Secretary at Polygon/Munters France-Belgium. Ms. Dumoussaud worked at Fournier/Solvay Pharma from 1997 to 2007, serving as the Finance Director from 2005 to 2007. Ms. Dumoussaud served as the Chief Financial Officer of Fournier Pharma Belgium from 2001 to 2004. Ms. Dumoussaud holds a Master in Business Management from the ISC Paris.
Follow Christelle Dumoussaud:
About ENTEROME: Enterome is a clinical-stage company developing drugs for chronic medical conditions relating to abnormalities of bacterial composition.
Chief Financial Officer of CellNovo
Erwan brings over 20 years of experience in finance, biotechnology and corporate development. Before joining Cellnovo, Erwan was Chief Financial Officer of Genomic Vision (Euronext: GV), a position he had held since 2009. He was also VP of Corporate Development until 2015, undertaking financing operations such as the Company’s initial public offering. He has also worked at Syndex, and co-founded Cytomics Pharmaceuticals, a biotechnology company specialising in the discovery of new medicines.
Follow Erwan Martin:
About CellNovo: CellNovo is a medical device company developing a wireless therapeutic system for diabetic patients.
Chief Financial Officer of CARMAT
A graduate of the ESCP Europe business school, Pascale d’Arbonneau is a member of the Association nationale des directeurs financiers et de contrôle de gestion, (DFCG, the French association of financial and management control managers) and a lecturer at Paris Diderot University. Before joining CARMAT, Pascale d’Arbonneau was Executive Director of the Econocom International B.V. (EIBV) family office. She began her career in 1989 as an auditor at Coopers & Lybrand (now PWC) before entering the pharmaceutical industry as Head of Finance & IT France at Johnson & Johnson – MSD (1995-1999). She spent most of her career (1999-2016) at GlaxoSmithKline (GSK). She joined as Director, Head of Controlling & Finance Partnering, France at GlaxoWellcome, just before its merger with SmithKline Beecham, managing a team of 20 people working on the combination of the two companies. She then held a number of senior positions within the Group (Vice President & Finance Controller, Pharma Europe from 2006 to 2010, Vice President & Area Finance Director, Western Europe from 2010 to 2014) before becoming Vice President Compliance and Control Integration for all business units worldwide.
Follow Pascale d’Arbonneau:
About CARMAT: CARMAT is a medtech company, offering biocompatible, auto-regulated total artificial hearts as close as possible to the human heart.
CFO of EOS Imaging
Valérie Worrall has over 20 years’ experience in Finance in the Healthcare industry. She had a long tenure with Novartis and worked in a number of their divisions. Her international career led her to the United States, South East Asia, Switzerland, Great Britain and France. Most recently, she was the CFO of Balt, a French medical device company. She joined EOS imaging in 2018 as the Chief Financial Officer. Valérie Worrall has a Masters in Management from HEC Paris.
Follow Valerie Worrall:
About EOS Imaging: EOS imaging designs, develops, and markets EOS®, a revolutionary and patented medical imaging system, based on technology.
Founder, CFO of Foobot
Olivier Vonet is an entrepreneur and CFO of AirBoxLab. Olivier has bathed in technology startups as well as high tech investment banking since business school.
Follow Olivier Vonet:
About Foobot: Foobot is an Indoor Air Quality Monitor to help people take control of their closest environment
CFO of Fermentalg
Bertrand Devillers is the chief financial officer of Fermentalg.
Follow Bertrand Devillers:
About Fermentalg: Fermentalg is engaged in the production of micro-algae for the agrifood, healthcare and energy markets.
Co-Founder & CFO of Enovap
Follow Valentin Delahaye:
About Enovap: Enovap is a intelligent dual-tank e-cigarette, designed and built to help smokers and vapers get full control of their nicotine intake.
Chief of Staff and Interim Chief Financial Officer of DBV Technologies
Sébastien Robitaille serves as Chief of Staff to the CEO and Deputy Chief Financial Officer, responsible for overseeing the global collective success drivers for the Company, leading the transformation from a development-stage biotechnology company to a potential commercial organization. He oversees Finance and Information Systems at Group level, and is a member of the Executive Committee. Mr. Robitaille brings extensive experience in the pharmaceutical industry and deep knowledge of performance management, forecasting and business modelling, transformation programs and implementation of strategic information systems. Mr. Robitaille joined DBV in 2015 as Senior Vice President, Group Controller & Information Systems and was subsequently named Deputy Chief Financial Officer. Prior to DBV, he worked at Ipsen for 15 years where he held various roles of increasing responsibility and participated in the company’s IPO. Mr. Robitaille received his Bachelor’s Degree in Business Administration-Finance from Paris School of Business.
Follow Sebastien Robitaille:
About DBV Technologies: DBV Technologies focuses on the development of innovative products for the diagnosis and treatment of food allergies.
Co-Founder and CFO of AgenT
Follow Baptiste Billoir:
About AgenT: AgenT develops the first blood diagnosis to detect Alzheimer’s years before the onset of the irreversible symptoms.